FindTrial
Sign In

JANX007

BIOLOGICAL2 trials

Sponsors

Janux Therapeutics

Conditions

Castration Resistant Prostatic CancerCastration-Resistant Prostate Cancer (CRPC)Metastatic Castration-Resistant Prostate Cancer PatientsMetastatic Castration-resistant Prostate CancerMetastatic Prostate CancerProstate Cancer

Phase 1

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RecruitingNCT05519449
Janux TherapeuticsCastration Resistant Prostatic Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer
Start: 2022-09-15End: 2028-12-01Target: 272Updated: 2026-08-13
Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC
RecruitingNCT07813637
Janux TherapeuticsCastration-Resistant Prostate Cancer (CRPC), Metastatic Castration-Resistant Prostate Cancer Patients, Metastatic Prostate Cancer +1
Start: 2026-09-10End: 2030-07-01Target: 110Updated: 2026-09-17